|
|
|
||||
| Home Help Feedback Subscriptions Archive Search Table of Contents | |||||
First published online March 7, 2007
doi: 10.1242/10.1242/jcs.03403
Research Article |
1 Developmental Biology Program, Sloan-Kettering Institute, Memorial Sloan-Kettering Cancer Center, New York, NY 10021, USA
2 Department of Orthopedic Surgery, Keio University, School of Medicine, Tokyo 160-8582, Japan
3 Department of Biochemical and Analytical Pharmacology, GlaxoSmithKline Inc., Research Triangle Park, NC 27709, USA
4 Arthritis and Tissue Degeneration Program, Hospital for Special Surgery, New York, NY 10021, USA
5 Departments of Medicine and of Physiology and Biophysics, Weill Medical College of Cornell University, New York, NY 10021, USA
* Authors for correspondence (e-mail: p-besmer{at}ski.mskcc.org; blobelc{at}hss.edu)
Accepted 10 January 2007
Kit ligand (Kitl), the ligand for the Kit receptor tyrosine kinase, plays important roles in hematopoiesis, gametogenesis and melanogenesis. Kitl is synthesized as a membrane-anchored precursor that can be processed to produce the soluble growth factor. Here, we evaluated the role of ADAM (a disintegrin and metalloprotease) metalloproteases in ectodomain shedding of Kitl. We found that both ADAM17 and ADAM19 affect Kitl1 shedding, albeit in different ways. Overexpression of ADAM19 resulted in decreased levels of Endo-H-resistant mature Kitl1, thereby reducing the amount of Kitl that is shed from cells following stimulation with phorbol esters. ADAM17 was identified as the major phorbol-ester-stimulated sheddase of Kitl1, whereas ADAMs 8, 9, 10, 12 and 15 were not required for this process. ADAM17 also emerged as the major constitutive and phorbol-ester-stimulated sheddase of Kitl2 in mouse embryonic fibroblasts. Mutagenesis of the juxtamembrane domain of Kitl2 showed no stringent sequence requirement for cleavage by ADAM17, although two nonadjacent stretches of four amino acid residues were identified that are required for Kitl2 shedding. Taken together, this study identifies a novel sheddase, ADAM17, for Kitl1 and Kitl2, and demonstrates that ADAM19 can reduce ADAM17-dependent phorbol-ester-stimulated Kitl1 ectodomain shedding.
Key words: Kit ligand, ADAM17, ADAM19, Ectodomain shedding
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati
Twitter What's this?
This article has been cited by other articles:
![]() |
M. Sisto, S. Lisi, D. D. Lofrumento, M. A. Frassanito, L. Cucci, S. D'Amore, V. Mitolo, and M. D'Amore Induction of TNF-alpha-converting enzyme-ectodomain shedding by pathogenic autoantibodies Int. Immunol., October 23, 2009; (2009) dxp103v1. [Abstract] [Full Text] [PDF] |
||||
![]() |
C.-W. Franzke, L. Bruckner-Tuderman, and C. P. Blobel Shedding of Collagen XVII/BP180 in Skin Depends on Both ADAM10 and ADAM9 J. Biol. Chem., August 28, 2009; 284(35): 23386 - 23396. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Horiuchi, H. Morioka, H. Takaishi, H. Akiyama, C. P. Blobel, and Y. Toyama Ectodomain Shedding of FLT3 Ligand Is Mediated by TNF-{alpha} Converting Enzyme J. Immunol., June 15, 2009; 182(12): 7408 - 7414. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. M. Le Gall, P. Bobe, K. Reiss, K. Horiuchi, X.-D. Niu, D. Lundell, D. R. Gibb, D. Conrad, P. Saftig, and C. P. Blobel ADAMs 10 and 17 Represent Differentially Regulated Components of a General Shedding Machinery for Membrane Proteins Such as Transforming Growth Factor {alpha}, L-Selectin, and Tumor Necrosis Factor {alpha} Mol. Biol. Cell, March 15, 2009; 20(6): 1785 - 1794. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Horiuchi, T. Kimura, T. Miyamoto, K. Miyamoto, H. Akiyama, H. Takaishi, H. Morioka, T. Nakamura, Y. Okada, C. P. Blobel, et al. Conditional Inactivation of TACE by a Sox9 Promoter Leads to Osteoporosis and Increased Granulopoiesis via Dysregulation of IL-17 and G-CSF J. Immunol., February 15, 2009; 182(4): 2093 - 2101. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. J. Levine Molecular Mechanisms of Soluble Cytokine Receptor Generation J. Biol. Chem., May 23, 2008; 283(21): 14177 - 14181. [Abstract] [Full Text] [PDF] |
||||